These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9162431)

  • 1. Hypertension and lipids.
    Sznajderman M
    Blood Press Suppl; 1996; 1():14-7. PubMed ID: 9162431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic and cardiovascular characteristics of hypertension. Familial aspects.
    Neutel JM; Smith DH
    Cardiol Clin; 1995 Nov; 13(4):539-47. PubMed ID: 8565017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of cardiovascular risk factors during antihypertensive treatment: current and new approach trends. The urapidil experience.
    Leonetti G
    Blood Press Suppl; 1994; 4():49-52. PubMed ID: 7804513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid lowering: another method of reducing blood pressure?
    Wierzbicki AS
    J Hum Hypertens; 2002 Nov; 16(11):753-60. PubMed ID: 12444536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood pressure parameters and cardiovascular risk in the elderly].
    Blacher J; Henry O; Girerd X; Safar M
    Ann Cardiol Angeiol (Paris); 1999 Sep; 48(7):489-93. PubMed ID: 12555371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
    Portolés J; López-Gómez JM; Aljama P
    Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk factors and their interactions in hypertensives.
    Lindholm LH
    J Hypertens Suppl; 1991 Dec; 9(3):S3-6. PubMed ID: 1797997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany.
    Raum E; Lietzau S; Stegmaier C; Brenner H; Rothenbacher D
    Pharmacoepidemiol Drug Saf; 2008 May; 17(5):485-94. PubMed ID: 18383562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypertension and hyperlipidemia].
    Hansen HS; Larsen ML
    Ugeskr Laeger; 2009 Jun; 171(24):2028-30. PubMed ID: 19523369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antihypertensive drug therapy in relation to lipid disorders].
    Kawecka-Jaszcz K; Stochmal A
    Przegl Lek; 1998; 55(2):85-8. PubMed ID: 9695649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
    Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
    Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification for the prevention of cardiovascular complications of hypertension.
    Girerd X; Giral P
    Curr Med Res Opin; 2004 Jul; 20(7):1137-42. PubMed ID: 15265258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence with treatment in newly treated middle-aged patients with essential hypertension.
    Perreault S; Lamarre D; Blais L; Dragomir A; Berbiche D; Lalonde L; Laurier C; St-Maurice F; Collin J
    Ann Pharmacother; 2005 Sep; 39(9):1401-8. PubMed ID: 16076920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of treating hyperlipidemia or hypertension to reduce the risk of death from coronary artery disease.
    Perreault S; Dorais M; Coupal L; Paradis G; Joffres MR; Grover SA
    CMAJ; 1999 May; 160(10):1449-55. PubMed ID: 10352634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.
    Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK
    J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antihypertensive treatment for patients with hypertension and diabetes type II--current clinical research].
    Rajzer M; Kawecka-Jaszcz K; Wojciechowska W
    Przegl Lek; 2003; 60(2):111-5. PubMed ID: 12939858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypertension and cardiovascular damage].
    Zanchetti A
    Ann Ital Med Int; 1992; 7(3 Suppl):97S-99S. PubMed ID: 1297404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.